Comparison of cystoscopy with diffusion-weighted magnetic resonance images used in the diagnosis and follow-up of patients with bladder tumors

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 4, 2010, Pages 1001-1004

  Ceylan, Kadir ^a   Taken, Kerem ^a   Gecit, Ilhan ^a   Pirincci, Necip ^a   Gunes, Mustafa ^a   Tanik, Serhat ^a   Karaman, Ihsan ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650695132     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Abou-El-Ghar ME, El-Assmy A, Refaie HF, et al (2009). Bladder cancer: Diagnosis with weighted MR imaging in patients with gross hematuria. Radiology, 251, 415-21.
2. Amendola MA, Glazer GM, Grossman HB, et al (1986). Staging of bladder carcinoma: MRI-CT-surgical correlation. AJR, 146, 1179-83.
3. Barentsz JO, Jager GJ, Witjes JA, et al (1996). Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur Radiol, 6, 129-33.
4. El-Assmy A, Abou-El-Ghar ME, Refaie HF, et al (2008). Diffusion-weighted MR imaging in diagnosis of superficial and invasive urinary bladder carcinoma: a preliminary prospective study. Sci World J, 8, 364-70.
5. Jemal A, Siegel R, Ward E, et al (2006). Cancer statistics 2006. CA Cancer J Clin, 56, 106-30.
6. Konety BR, Metro MJ, Melham MF, et al (1998). Urology. 52, 398-402.
7. Konety BR, Metro MJ, Melham MF, et al (1999). Diagnostic value of voided urine barbotage cytology in detecting transitional cell carcinoma of the urinary tract. Urol Int, 62, 26-30.
8. Landman J, Chang Y, Kavaler E, et al (1998). Sensitivity and specificity of NMP-22, telomerase and BTA in the detection of human bladder cancer. Urology, 52, 398-402.
9. Lawler LP, Fishman EK (2003). Bladder imaging using multidetector row computed tomography, volume rendering and magnetic resonance imaging. J Comput Assist Tomogr, 27, 553-63.
10. Leyh H, Marberger M, Conort P, et al (1999). Comparison of BTA Stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer. Eur Urol, 35, 52-6
11. Matsuki M, Inada Y, Tatsugami F, et al (2007). Diffüsion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol, 17, 201-4.
12. Schmidbauer J, Lindenau G (2008). Follow-up of nonmuscle invasive transitional cell carcinoma of the bladder: how and how often? Curr Opin Urol, 18, 504-7.
13. Tinzl M, Marberger M (2003). Urinary markers for detecting bladder cancer. EAU Update Series vol, 1, 64-70.
14. Walsh PC, Retik AB, Vaughan ED, et al (2005). Campell Urology, 2732-73.
15. Walker L, Liston TGL, Loyd-Davies RW (1993). Does flexible cystoscopy miss more tumors than rod-lens examination? Br J Urol, 72, 449-50
16. Wright M, Jones D (2000). Surveillance for bladder cancer the management of 4.8 million people. BJU Int, 85, 431-3.
17. Yoshi{dotless}da S, Masuda H, Ishii C, et al (2008). Initial experience of functional imaging of upper urinary bladder tract neoplasm by diffusion-weighted magnetic resonance imaging. Int J Urol, 15, 140-3.